Unknown

Dataset Information

Predictors of pulmonary exacerbation treatment in cystic fibrosis.


ABSTRACT:

Background

Most studies of pulmonary exacerbations (PEx) in cystic fibrosis (CF) focus on intravenous (IV)-treated PEx, though most PEx are treated with oral antibiotics. Our objectives were to describe predictors of antibiotic choice and outcomes for PEx initially identified in clinic.

Methods

For each patient in the U.S. CF Foundation Patient Registry, we selected the first PEx recorded at a clinic visit in 2013-14 following a clinic visit without a PEx. We used multivariable logistic regression to determine associations between clinical characteristics and antibiotic treatment choice. We determined outcomes in the 90 days after the first PEx.

Results

Among 14,265 patients with a PEx initially identified in clinic, 21.4% received no antibiotics, 61.5% received new o

SUBMITTER: Sanders DB 

PROVIDER: S-EPMC6940539 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature